References:
1. Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et
al. An International Urogynecological Association (IUGA)/International
Continence Society (ICS) joint report on the terminology for female
pelvic floor dysfunction. Neurourology and Urodynamics: Official Journal
of the International Continence Society. 2010;29(1):4-20.
2. McDougal WS, Wein AJ, Kavoussi LR, Partin AW, Peters CA.
Campbell-Walsh Urology 11th Edition Review E-Book: Elsevier Health
Sciences; 2015.
3. Shirvan MK, Alamdar DH, Ghorifi A, Rahimi HR. A novel treatment for
urethrovaginal fistula: autologous platelet-rich–plasma injection and
platelet-rich–fibrin-glue interposition. Journal of Gynecologic
Surgery. 2013;29(5):268-70.
4. Gomelsky A, Dmochowski RR. Treatment of mixed urinary incontinence.
Central European journal of urology. 2011;64(3):120.
5. Committee on Practice B-G, the American Urogynecologic S. ACOG
Practice Bulletin No. 155 Summary: Urinary Incontinence in Women. Obstet
Gynecol. 2015;126(5):1120-2.
6. Labrie J, Berghmans BL, Fischer K, Milani AL, Van Der Wijk I,
Smalbraak DJ, et al. Surgery versus physiotherapy for stress urinary
incontinence. New England Journal of Medicine. 2013;369(12):1124-33.
7. Kulseng-Hanssen S, Husby H, Schiøtz HA. Follow-up of TVT operations
in 1,113 women with mixed urinary incontinence at 7 and 38 months.
International Urogynecology Journal. 2008;19(3):391-6.
8. Kuo HC. Botulinun A toxin urethral sphincter injection for neurogenic
or nonneurogenic voiding dysfunction. Tzu Chi Medical Journal. 2016 Sep
1;28(3):89-93
9. PHELAN MW, FRANKS M, SOMOGYI GT, YOKOYAMA T, FRASER MO, LAVELLE JP,
YOSHIMURA N, CHANCELLOR MB. Botulinum toxin urethral sphincter injection
to restore bladder emptying in men and women with voiding dysfunction.
The Journal of urology. 2001 Apr;165(4):1107-10.
10. Shirvan MK, Alamdari DH, Mahboub MD, Ghanadi A, Rahimi HR, Seifalian
AM. A novel cell therapy for stress urinary incontinence, short‐term
outcome. Neurourology and urodynamics. 2013 Apr;32(4):377-82.